LUCIANNE WIGGINS: Open Payments
NPI 1871893883 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 13 payments from 8 companies in 2025. Trend: 2023 $865 · 2024 $953 · 2025 $389
Food & beverage: $370Education: $19
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $102 |
| Medtronic, Inc. | 1 | $84 |
| Corium, LLC | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| ABBVIE INC. | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: EVENITY, MINIMED 780G, Azstarys, AIRSUPRA, UBRELVY, TRELEGY ELLIPTA, Kerendia, JARDIANCE.
Industry payments across AL — which companies pay providers there.
